Stallergenes gets European approval for dust mite allergy tablet

Stallergenes Greer, which is based in France, will compete with ALK within the indication.
Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750
Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT

ALK's archrival, Stallergenes Greer, is closing in on the lucrative allergy pill market, which ALK has called one of the most important future growth markets.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading